The SchlaHF XT Registry is a longitudinal study of patients with heart failure (HF). The study aims to understand the importance of diagnosis and treatment of sleep disordered breathing (SDB) on HF with the following questions: How often does SDB occur in HF? What forms of SDB occur and how are they treated? How does SDB develop over time? How does the heart failure therapy affect SDB? What is the treatment adherence of patients treated? Does SBD and its treatment affect the survival of heart failure patients?
Study Type
OBSERVATIONAL
Enrollment
4,749
Heart and Diabetes Centre
Bad Oeynhausen, North Rhine-Westphalia, Germany
Number of heart failure patients with sleep disordered breathing (apnea hypopnoea index >5)
Assess the changes in prevalence of SDB in HF from baseline to 5 years
Time frame: 5 years
Number of heart failure patients with sleep disordered breathing (apnea hypopnea index >5) when exposed to sleep disordered breathing treatment
Assess changes in sleep disordered breathing when exposed to treatment from baseline to 5 years
Time frame: 5 years
Number of heart failure patients with sleep disordered breathing (apnea hypopnea index >5) when exposed to Heart Failure treatment
Assess changes in SDB when the patient is treated with heart failure therapy
Time frame: 5 years
Number of patients adherent to sleep disordered breathing treatment as measured by device reported usage hours
Assess adherence rates to treatment
Time frame: 5 years
Number of deaths of patients with HF and sleep disordered breathing (apnea hypopnoea index >5) who are treated for sleep disordered breathing
Assess survival rates of HF patients who are treated for sleep disordered breathing
Time frame: 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.